JPS604190A - Preparation of cephalosporin derivative - Google Patents
Preparation of cephalosporin derivativeInfo
- Publication number
- JPS604190A JPS604190A JP58111537A JP11153783A JPS604190A JP S604190 A JPS604190 A JP S604190A JP 58111537 A JP58111537 A JP 58111537A JP 11153783 A JP11153783 A JP 11153783A JP S604190 A JPS604190 A JP S604190A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- group
- lower alkyl
- benzylideneimino
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001780 cephalosporins Chemical class 0.000 title claims description 4
- 229930186147 Cephalosporin Natural products 0.000 title claims description 3
- 229940124587 cephalosporin Drugs 0.000 title claims description 3
- 150000001875 compounds Chemical class 0.000 claims abstract description 18
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 7
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims abstract description 7
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 4
- 150000003839 salts Chemical class 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 4
- 125000003277 amino group Chemical group 0.000 claims description 3
- 125000004429 atom Chemical group 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 3
- 125000001424 substituent group Chemical group 0.000 claims description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 abstract description 6
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 abstract description 5
- 239000002904 solvent Substances 0.000 abstract description 4
- 229940043279 diisopropylamine Drugs 0.000 abstract description 2
- BDSDFCVDQUGOFB-SVGQVSJJSA-N (6r,7r)-7-amino-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound S1CC(COC)=C(C(O)=O)N2C(=O)[C@@H](N)[C@@H]12 BDSDFCVDQUGOFB-SVGQVSJJSA-N 0.000 abstract 1
- XZVBIIRIWFZJOE-UHFFFAOYSA-N 1-iodoethyl propan-2-yl carbonate Chemical compound CC(C)OC(=O)OC(C)I XZVBIIRIWFZJOE-UHFFFAOYSA-N 0.000 abstract 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 abstract 1
- 125000005599 alkyl carboxylate group Chemical group 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 36
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- -1 isodityl Chemical group 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 239000012267 brine Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- YSULOORXQBDPCU-UHFFFAOYSA-N 2-(trimethylazaniumyl)ethanehydrazonate;hydrochloride Chemical compound [Cl-].C[N+](C)(C)CC(=O)NN YSULOORXQBDPCU-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 2
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- NIDNOXCRFUCAKQ-UMRXKNAASA-N (1s,2r,3s,4r)-bicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid Chemical compound C1[C@H]2C=C[C@@H]1[C@H](C(=O)O)[C@@H]2C(O)=O NIDNOXCRFUCAKQ-UMRXKNAASA-N 0.000 description 1
- QIJIUJYANDSEKG-UHFFFAOYSA-N 2,4,4-trimethylpentan-2-amine Chemical compound CC(C)(C)CC(C)(C)N QIJIUJYANDSEKG-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- VGEHZXVGFAMPSQ-UHFFFAOYSA-N C(C)(I)C(C)(Cl)C Chemical compound C(C)(I)C(C)(Cl)C VGEHZXVGFAMPSQ-UHFFFAOYSA-N 0.000 description 1
- 102100024479 Cell division cycle-associated protein 3 Human genes 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- 101000980907 Homo sapiens Cell division cycle-associated protein 3 Proteins 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical class [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- WARCRYXKINZHGQ-UHFFFAOYSA-N benzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1 WARCRYXKINZHGQ-UHFFFAOYSA-N 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- RUDATBOHQWOJDD-BSWAIDMHSA-N chenodeoxycholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-BSWAIDMHSA-N 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- XXBDWLFCJWSEKW-UHFFFAOYSA-N dimethylbenzylamine Chemical compound CN(C)CC1=CC=CC=C1 XXBDWLFCJWSEKW-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000006606 n-butoxy group Chemical group 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- ODUCDPQEXGNKDN-UHFFFAOYSA-N nitroxyl Chemical compound O=N ODUCDPQEXGNKDN-UHFFFAOYSA-N 0.000 description 1
- 229940124588 oral cephalosporin Drugs 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 1
- 229940067157 phenylhydrazine Drugs 0.000 description 1
- XIPFMBOWZXULIA-UHFFFAOYSA-N pivalamide Chemical compound CC(C)(C)C(N)=O XIPFMBOWZXULIA-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- XHFLOLLMZOTPSM-UHFFFAOYSA-M sodium;hydrogen carbonate;hydrate Chemical compound [OH-].[Na+].OC(O)=O XHFLOLLMZOTPSM-UHFFFAOYSA-M 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 150000004992 toluidines Chemical class 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Cephalosporin Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は一般式
(式中 11は水素原子または低級アルキル基を示し
12は低級アルキル基または低級アルコキシ基を示す。Detailed Description of the Invention The present invention is based on the general formula (wherein 11 represents a hydrogen atom or a lower alkyl group)
12 represents a lower alkyl group or a lower alkoxy group.
)
を有するセファロスポリン誘導体及びその酸付加塩の新
規な製法に関するもので、更に詳しく一般式
(式中、Aはアミノ基または置換基を有するか有しない
ベンジリデンイミノ基を示す。)を有する化合物に塩基
の存在下、
一般式
(式中 R1およびR2は前述したものと同意義を示し
、Xは)・ログン原子を示す。)を有する化合物を反応
せしめ、Aがベンジリデンイミノ基である場合には、ベ
ンジリデン基を脱離することを特徴とする前記一般式(
1)を有する化合物及びその酸付加塩の製法に関するも
のである。) and relates to a new method for producing cephalosporin derivatives and acid addition salts thereof, more specifically compounds having the general formula (wherein A represents an amino group or a benzylideneimino group with or without a substituent). In the presence of a base, the general formula (wherein R1 and R2 have the same meanings as described above, and X represents a rogone atom) is obtained. ), and when A is a benzylidene imino group, the benzylidene group is eliminated.
The present invention relates to a method for producing a compound having 1) and an acid addition salt thereof.
上記式中 R1は好適には水素原子またはメチル基を示
し R2はメチル、エチル、n−プロピル、イソプロピ
ル、n−ブチル、イソジチル、臓−ブチル、tert−
ブチルのような炭素数1乃至4を有する直鎖状若しくは
分枝鎖状のアルキル基またはメトキシ、エトキシ、n−
グロポキシ、インシトキシ、n−ブトキシ、インシトキ
シ、(8)−ブトキシ、tart−シトキシのような炭
素数1乃至4個を有する直鎖状若しくは分枝鎖状のアル
コキシ基を示し、Aはアミン基またはベンジリデンイミ
ノ若しくはサリチリデンイミノのような非置換若しくは
置換ベンジリデンイミノ基を示し、Xは臭素または沃素
のようなハロダン原子を示す。In the above formula, R1 preferably represents a hydrogen atom or a methyl group, and R2 represents methyl, ethyl, n-propyl, isopropyl, n-butyl, isodityl, tert-butyl, and tert-butyl.
A linear or branched alkyl group having 1 to 4 carbon atoms such as butyl, methoxy, ethoxy, n-
It represents a linear or branched alkoxy group having 1 to 4 carbon atoms, such as glopoxy, incytoxy, n-butoxy, incytoxy, (8)-butoxy, and tart-cytoxy, and A is an amine group or benzylidene group. It represents an unsubstituted or substituted benzylideneimino group such as imino or salicylideneimino, and X represents a halodane atom such as bromine or iodine.
一般にこのような本発明の化合物の従来法による製法と
しては、セファロスポリン骨格の7位をアシル化し、つ
いで4位カルビン酸のエステル化、ついで五塩化燐等に
よるイミノエーテル法によってアシル基を切断して実施
されていた。本発明の方法によれば、このような五塩化
燐によるアシル基切断等煩雑な操作を必要とせず容易に
目的物を得る事ができる。In general, the conventional method for producing such compounds of the present invention involves acylating the 7-position of the cephalosporin skeleton, then esterifying carbic acid at the 4-position, and then cleaving the acyl group by an iminoether method using phosphorus pentachloride or the like. It was carried out as follows. According to the method of the present invention, the desired product can be easily obtained without requiring complicated operations such as cleavage of acyl groups with phosphorus pentachloride.
本発明の方法を実施するにあたって、前記一般式(II
)を有する化合物を一般式(至)を有する化合物と塩基
の存在下で反応させるエステル化反応は、溶剤の存在下
で行なうことができる。使用される溶剤としては反応に
関与しないものであれば特に限定はないが、例えばジメ
チルホルムアミド、ジメチルアセトアミドのような脂肪
酸ジアルキルアミド類またはこれらとソクロルメタン、
メタノールのような有機溶剤との混合溶剤が好適である
。反応に使用される塩基としてはトリエチルアミン、ツ
インプロピルアミン、tart−オクチルアミン、ジメ
チル−ベンジルアミン、ジシクロヘキシルアミンのよう
な有機塩基が好適である。反応温度は通常、−10℃乃
至室温付近であシ、反応時間は反応温度、反応試剤(曲
の種類などによって異なるが、通常、30分乃至2時間
である。In carrying out the method of the present invention, the general formula (II
) can be reacted with a compound having the general formula (-) in the presence of a base, which can be carried out in the presence of a solvent. The solvent used is not particularly limited as long as it does not participate in the reaction, but for example, fatty acid dialkylamides such as dimethylformamide and dimethylacetamide, or these together with sochloromethane,
A mixed solvent with an organic solvent such as methanol is preferred. Suitable bases used in the reaction are organic bases such as triethylamine, twinpropylamine, tart-octylamine, dimethyl-benzylamine, and dicyclohexylamine. The reaction temperature is usually around -10°C to room temperature, and the reaction time is usually 30 minutes to 2 hours, although it varies depending on the reaction temperature, reaction reagent (type of music, etc.).
本エステル化反応によって得られる化合物において、置
換基Aがベンジリデンアミノ基を表わす場合には、常法
に従ってベンジリデン基を脱離することができる。その
目的のための脱離試薬としてシッフ塩基化合物よジアミ
ノ基を再生するものであれば特に限定はないが、好適に
はジラードT試薬、フェニルヒドラジンまたはその塩酸
塩、アセテルヒドラソン、ベンゾイルヒドラジン、アニ
リン、トルイジンのような有機塩基又はそれらの酢酸ま
たはシュウ酸等の酸付加塩をあげることができる。In the compound obtained by this esterification reaction, when substituent A represents a benzylidene amino group, the benzylidene group can be removed according to a conventional method. As an elimination reagent for that purpose, there is no particular limitation as long as it regenerates the diamino group, such as a Schiff base compound, but preferred examples include Girard T reagent, phenylhydrazine or its hydrochloride, acetelhydrazone, benzoylhydrazine, Examples include organic bases such as aniline and toluidine, and acid addition salts thereof such as acetic acid or oxalic acid.
反応終了後、本反応の目的化合物(1)は常法に従って
反応混合物から採取することができる。After the reaction is completed, the target compound (1) of this reaction can be collected from the reaction mixture according to a conventional method.
例えば、反応混合物を酢酸エチルのような有機溶剤で抽
出し、有機溶剤層を水洗し乾燥することによって得るこ
とができる。このようにして得られた目的化合物は必要
ならば常法に従って、例えば塩酸塩、臭化水素酸塩、ベ
ンゼンスルホンTIN塩、p −)ルエンスルホン酸塩
、α−若L<iiβ−ナフタレンスルホン酸塩のような
酸付加塩として精製することができる。For example, it can be obtained by extracting the reaction mixture with an organic solvent such as ethyl acetate, washing the organic solvent layer with water, and drying. The target compound thus obtained can be prepared, if necessary, by conventional methods, such as hydrochloride, hydrobromide, benzenesulfone TIN salt, p-)luenesulfonate, α-L<iiβ-naphthalenesulfonic acid. It can be purified as an acid addition salt such as a salt.
本発明の目的化合物(1)は、抗菌作用を有する医薬の
原料として有用である。例えば本化合物(1)を中間体
として特開昭57−59894号明細書に記載されてい
るような経口用セファロスポリン化合物を製造すること
ができる。The object compound (1) of the present invention is useful as a raw material for pharmaceuticals having antibacterial activity. For example, an oral cephalosporin compound as described in JP-A-57-59894 can be produced using the present compound (1) as an intermediate.
次に実施例をあげて本発明の製法を更に具体的に説明す
る。Next, the manufacturing method of the present invention will be explained in more detail with reference to Examples.
実施例 1
7β−アミノ−3−メトキシメチル−3−セフェム−4
−カルボン酸5.01をN、N−ジメチルアセトアミド
50−に懸濁し、氷水浴中5℃以下に冷却し、攪拌しな
がら、ジインプロピルアミン3.4−を加え、ついでベ
ンツアルデヒド2.5m1lを加え30分間攪拌を続け
る、透明な溶液となる。Example 1 7β-amino-3-methoxymethyl-3-cephem-4
- 5.0 l of carboxylic acid was suspended in 50 - of N,N-dimethylacetamide, cooled to below 5°C in an ice-water bath, and while stirring, 3.4 - of diimpropylamine was added, followed by 2.5 ml of benzaldehyde. Add and continue stirring for 30 minutes, resulting in a clear solution.
これに1−ヨードエチルイソプロビルカーポネー)7.
5F!−を加え、1時間半攪拌し、ノラードT試薬7.
01をメタノール100rnlにとかした溶液を加え、
更に40分攪拌する。ついで減圧濃縮し、メタノールを
留去する。残留物に酢酸エチル100ゴを加え18%食
塩水60 ml及び20−で二回洗浄し、水層を更に酢
酸エチルが得られる。これを酢酸エチル50rnlに溶
解し、水50−を加え、攪拌しながら6NHCtを加え
−を1.8に調整し、食塩を加えると結晶が析出する。7.
5F! - was added, stirred for 1.5 hours, and Norard T reagent 7.
Add a solution of 01 dissolved in 100rnl of methanol,
Stir for an additional 40 minutes. Then, the mixture is concentrated under reduced pressure to distill off methanol. Add 100 ml of ethyl acetate to the residue and wash twice with 60 ml of 18% brine and 20 ml of 18% brine to obtain more ethyl acetate from the aqueous layer. Dissolve this in 50rnl of ethyl acetate, add 50ml of water, add 6N HCl while stirring to adjust the - to 1.8, and add salt to precipitate crystals.
沢果し、酢酸エチルで洗浄し、乾燥すると、2.59−
の標記化合物のエビャーの一方が塩酸塩として得られた
。When washed with ethyl acetate and dried, 2.59-
One of the title compounds was obtained as a hydrochloride.
融点186〜188℃(分解)
nmrスペクトル(CD、OD)δ:
1.30 二重線(6I(、J =6Hz )1.57
二重線(3H、J =6 Hz )3.37−重線(
3H)
3.7〇 −重線(2H)
4.40−重線(2H)
5.13 、5.30 四重量(2H、d、d 、 J
=5Hz )6.93 四重線(! H、J=6Hz
)この塩酸塩を炉去した炉液を分液し、酢酸エチル層を
とり、5%炭酸水素ナトリウム水、ついで水で洗浄し、
p−)ルエンスルホン酸2.5Iを加えてとかし、一度
減圧濃縮乾固し、酢酸エチルを加えて放置すると結晶が
析出する。これを炉集、酢酸エチルで洗浄後乾燥すると
、3.71の標記化合物の他方のエピマーのp−)ルエ
ンスルホン酸塩が得られた。Melting point 186-188°C (decomposed) nmr spectrum (CD, OD) δ: 1.30 Doublet (6I (, J = 6Hz) 1.57
Double line (3H, J = 6 Hz) 3.37 - Double line (
3H) 3.7〇 - Heavy line (2H) 4.40 - Heavy line (2H) 5.13 , 5.30 Four weights (2H, d, d, J
=5Hz)6.93 Quadruple (! H, J=6Hz
) The furnace liquor from which this hydrochloride was removed in the furnace was separated, the ethyl acetate layer was taken, and the layer was washed with 5% sodium bicarbonate water and then with water.
p-) Add 2.5 I of luenesulfonic acid and dissolve, once concentrate to dryness under reduced pressure, add ethyl acetate and leave to stand to precipitate crystals. This was collected in a furnace, washed with ethyl acetate, and dried to obtain p-)luenesulfonate of the other epimer of the title compound 3.71.
融点182〜183.5℃(分解)
nmrスペクトル(CD、OD)δ:
1.27 二重線(6H、J =6Hz )1.53
二重M(3H、J =6 Hz )2.37−重線(3
H)
3.37−重線(3H)
3.67−重線(2H)
4.33−重線(2H)
5.13 、5.27 四重線(2H、d、d 、 J
=5Hz )6.87 四1線(II(、J =6Hz
)7.23 、7.73 四重線(4HIA2B2.
J=9Hz)実施例 2
7β−アミノ−3−メトキシフチルー3−セフェム−4
−カルボン酸5.Qy−をN、N−ジメチルアセトアミ
ド5o−に懸濁し、氷水浴中5℃以下に冷却し、攪拌し
なからtert−オクチルアミン4.3−を加えて溶解
せしめ、1−ヨードエチルイソプロビルヵーポネー)7
.4Fを加え2時間攪拌を続ける。ついで酢酸エテル1
00−を加え、実施例1の如く処理すると、例1の標記
化合物6.01が得られ、例1の如く同様に操作すると
、塩酸塩2.1?及びp−トルエンスルホン酸塩3.0
g−が得られた。Melting point 182-183.5°C (decomposed) nmr spectrum (CD, OD) δ: 1.27 Doublet (6H, J = 6Hz) 1.53
Double M (3H, J = 6 Hz) 2.37-Double (3
H) 3.37-double (3H) 3.67-double (2H) 4.33-double (2H) 5.13, 5.27 quartet (2H, d, d, J
=5Hz)6.87 41st line (II(,J =6Hz
) 7.23, 7.73 quartet (4HIA2B2.
J=9Hz) Example 2 7β-amino-3-methoxyphthyl-3-cephem-4
-carboxylic acid5. Qy- was suspended in N,N-dimethylacetamide 5o-, cooled to below 5°C in an ice water bath, and while stirring, tert-octylamine 4.3- was added and dissolved, and 1-iodoethyl isopropyl chloride was added. - Pone) 7
.. Add 4F and continue stirring for 2 hours. Then ethyl acetate 1
00- and working up as in Example 1 gives 6.01 of the title compound of Example 1; working similarly as in Example 1 gives the hydrochloride 2.1? and p-toluenesulfonate 3.0
g- was obtained.
実施例 3
7β−アミノ−3−メトキシメチル−3−セフェム−4
−カルボン酸2.44fをツメチルアセトアミド25ゴ
に水冷下懸濁し、ジイソプロピルアミン1.IPを加え
てとかし、ベンツアルデヒド1.2 tdを加え30分
攪拌後ヒバロイルオキシメチルアイオダイド3.15
Pを加え、3℃で1時間30分攪拌する。ついでジラー
ドT試薬3.4Fをメタノール50fIttにとかした
溶液を加え、1時間攪拌する。メタノールを減圧留去し
残留物に酢酸エチル60−を加え、・18%食塩水30
7!で二回洗浄後減圧濃縮し、残留物をベンゼン:酢酸
エチル(1:1))
nmrスペクトル(CDCA3)δ:
1.23−重線(9H)
3.30−重線(3■)
3.48−重線(2■)
4.23−g@(2H)
4.63 、4.87 四重線(2H、d、d 、 J
=5Hz )5.80−重線(2H)
実施例 4
実施例3のピパロイルオキシメチルアイオダイド3.1
5fの代シにヨードメチルイングロビルカーがネー)3
.2iを用い、同様に反応せしマド溶媒、ベンゼン:酢
酸エチル 1:1)nmrスペクトル(CDCA、)δ
:
1.30 二重線(2H、J=6 Hz )3.31−
重線(3H)
3.51−重線(2H)
4.71,4.98 VfAX線(2H、d、d 、
J=5Hz )5.83−重線(2K)
実施例 5
実施例3のピパロイルオキシメチルアイオダイドの代フ
にヨードメチルエチルカーがネートnmrスペクト#
(CDCA3)δ:1.32三重線(3H、J=7Hz
)3.26−重線(3H)
3.50−重線(3■)
4.16 四重線(2H,J=7Hz)4.67 、4
.85 四重線(2H、d、d 、 J=5Hz )5
.80−重線(2H)
特許出願人 三共株式会社
代理人 弁理士 樫出庄治Example 3 7β-amino-3-methoxymethyl-3-cephem-4
- 2.44f of carboxylic acid was suspended in 25g of trimethylacetamide under water cooling, and 1.4f of diisopropylamine was suspended in 25g of dimethylacetamide. Add and dissolve IP, add 1.2 td of benzaldehyde and stir for 30 minutes, then add 3.15 td of hivaloyloxymethyl iodide.
Add P and stir at 3°C for 1 hour and 30 minutes. Then, a solution of 3.4F Girard T reagent dissolved in 50fItt of methanol is added and stirred for 1 hour. Methanol was distilled off under reduced pressure, 60% of ethyl acetate was added to the residue, and 30% of 18% brine was added.
7! After washing twice with , it was concentrated under reduced pressure, and the residue was purified using benzene:ethyl acetate (1:1). 48-Double line (2■) 4.23-g@(2H) 4.63, 4.87 Quadruple line (2H, d, d, J
=5Hz) 5.80-duplex (2H) Example 4 Piparoyloxymethyl iodide of Example 3 3.1
Iodomethyl inglovir car is substituted for 5f) 3
.. 2i, reacted in the same manner as solvent, benzene:ethyl acetate 1:1) nmr spectrum (CDCA, ) δ
: 1.30 Double line (2H, J=6 Hz) 3.31-
Heavy line (3H) 3.51-Double line (2H) 4.71, 4.98 VfAX ray (2H, d, d,
J=5Hz) 5.83-double line (2K) Example 5 In place of the piparoyloxymethyl iodide of Example 3, iodomethylethyl car was used as a nate nmr spectrum #
(CDCA3) δ: 1.32 triplet (3H, J=7Hz
) 3.26-double line (3H) 3.50-double line (3■) 4.16 Quadruple line (2H, J=7Hz) 4.67, 4
.. 85 Quadruple (2H, d, d, J=5Hz) 5
.. 80-Double line (2H) Patent applicant: Sankyo Co., Ltd. Agent Patent attorney: Shoji Kashide
Claims (1)
ベンジリデンイミノ基を示す。)を有する化合物に塩基
の存在下、 一般式 (式中、R1は水素原子または低級アルキル基を示し
B2は低級アルキル基または低級アルコキシ基を示し、
Xはハロダン原子を示す@)を有する化合物を反応せし
め、Aがベンジリデンイミノ基の場合には、ベンジリデ
ン基を脱離することを特徴とする 一般式 (式中 R1およびR2は前述したものと同意義を示す
。) を有するセファロスポリン誘導体及びその酸付加塩の製
法。[Scope of Claims] In the presence of a base, a compound having the general formula (wherein A represents an amine group or a benzylideneimino group with or without a substituent) is treated with the general formula (wherein R1 is a hydrogen atom). or lower alkyl group
B2 represents a lower alkyl group or a lower alkoxy group,
A general formula (wherein R1 and R2 are the same as those described above) is reacted with a compound having @) where X represents a halodane atom, and when A is a benzylidene imino group, the benzylidene group is eliminated. A process for producing a cephalosporin derivative and an acid addition salt thereof having the following.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58111537A JPS604190A (en) | 1983-06-21 | 1983-06-21 | Preparation of cephalosporin derivative |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58111537A JPS604190A (en) | 1983-06-21 | 1983-06-21 | Preparation of cephalosporin derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS604190A true JPS604190A (en) | 1985-01-10 |
Family
ID=14563866
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58111537A Pending JPS604190A (en) | 1983-06-21 | 1983-06-21 | Preparation of cephalosporin derivative |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS604190A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5410042A (en) * | 1992-05-21 | 1995-04-25 | Hoechst Aktiengesellschaft | Process for the cleavage of cephalosporin prodrug esters to 7-amino-3-methoxymethylceph-3-em-4-carboxylic acid |
| US5461043A (en) * | 1991-09-07 | 1995-10-24 | Hoechst Aktiengesellschaft | Diastereomers of 1-(isopropoxycarbonyloxy)ethyl 3-cephem-4-carboxylate |
| LT3870B (en) | 1993-11-30 | 1996-04-25 | Hoechst Ag | Diastereomers of 3-cefem-4-carboxylic acid 1-(isopropoxy-carbonyloxy)ethyl ester, process for preparingthereof, antibacteric preparations based on same and process for preparation thereof |
| US5589594A (en) * | 1992-02-14 | 1996-12-31 | Hoechst Aktiengesellschaft | Process for the preparation of cephem prodrug esters |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS49132097A (en) * | 1972-10-05 | 1974-12-18 | ||
| JPS57169489A (en) * | 1981-04-13 | 1982-10-19 | Sankyo Co Ltd | Cephalosporin derivative and its preparation |
-
1983
- 1983-06-21 JP JP58111537A patent/JPS604190A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS49132097A (en) * | 1972-10-05 | 1974-12-18 | ||
| JPS57169489A (en) * | 1981-04-13 | 1982-10-19 | Sankyo Co Ltd | Cephalosporin derivative and its preparation |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5461043A (en) * | 1991-09-07 | 1995-10-24 | Hoechst Aktiengesellschaft | Diastereomers of 1-(isopropoxycarbonyloxy)ethyl 3-cephem-4-carboxylate |
| US5550232A (en) * | 1991-09-07 | 1996-08-27 | Hoechst Aktiengesellschaft | Diastereomers of 1-(isopropoxycarbonyloxy) ethyl 3-cephem 4-carboxylate |
| US5614623A (en) * | 1991-09-07 | 1997-03-25 | Hoechst Aktiengesellschaft | Diastereomers of 1-(isopropoxycarbonyloxy)ethyl 3-cephem-4-carboxylate and processes for their preparation |
| US5589594A (en) * | 1992-02-14 | 1996-12-31 | Hoechst Aktiengesellschaft | Process for the preparation of cephem prodrug esters |
| US5637721A (en) * | 1992-02-14 | 1997-06-10 | Hoechst Aktiengesellschaft | Process for the preparation of cephem prodrug esters |
| US5410042A (en) * | 1992-05-21 | 1995-04-25 | Hoechst Aktiengesellschaft | Process for the cleavage of cephalosporin prodrug esters to 7-amino-3-methoxymethylceph-3-em-4-carboxylic acid |
| LT3870B (en) | 1993-11-30 | 1996-04-25 | Hoechst Ag | Diastereomers of 3-cefem-4-carboxylic acid 1-(isopropoxy-carbonyloxy)ethyl ester, process for preparingthereof, antibacteric preparations based on same and process for preparation thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0149271B2 (en) | ||
| JPH0362711B2 (en) | ||
| JPS5834474B2 (en) | Method for producing thiazolidine derivatives | |
| JPH05247013A (en) | Novel oxime derivative of aminothiazolyl acetic acid and preparation thereof | |
| JPS6339869A (en) | Novel oxime derivative of aminothiazolylacetic acid and its production | |
| JP3751880B2 (en) | Method for producing high-purity cefpodoxime proxetil | |
| JPH041757B2 (en) | ||
| JP4303792B2 (en) | Method for producing quinolone derivative | |
| JPS6178791A (en) | Manufacture of cephem derivative | |
| JPH0134219B2 (en) | ||
| JPH0454674B2 (en) | ||
| JPS61225183A (en) | Manufacture of beta-carboline | |
| CA1280409C (en) | Method of producing cephem compounds | |
| US5998611A (en) | Process for producing cephem compounds in an aqueous medium | |
| JPH02167289A (en) | Production of novel cephalosporin derivative | |
| JPS6052754B2 (en) | 7-amino-3-halogenomethyl-△↑3-cephem-4-carboxylic acids and their production method | |
| JPS63500721A (en) | New manufacturing method for chemical compounds | |
| JPS6324994B2 (en) | ||
| JP3495417B2 (en) | Method for producing 2-alkoxy-3,5-dihalogeno-6-nitrobenzoic acids | |
| JPS58159496A (en) | Cephem-based compound | |
| KR890000523B1 (en) | Process for preparing cephalosporin derivatives | |
| JPS643197B2 (en) | ||
| JPS6126998B2 (en) | ||
| JPS6124568A (en) | Method for producing dihydropyridine ester | |
| JPS6110569A (en) | Preparation of 2-(2-aminothiazole)-acetic acid derivative |